L'IMPERIO, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 12.973
AS - Asia 11.380
EU - Europa 7.765
SA - Sud America 1.564
AF - Africa 279
OC - Oceania 40
Continente sconosciuto - Info sul continente non disponibili 4
Totale 34.005
Nazione #
US - Stati Uniti d'America 12.271
SG - Singapore 4.123
IT - Italia 2.867
VN - Vietnam 2.122
CN - Cina 2.092
HK - Hong Kong 1.235
BR - Brasile 1.155
RU - Federazione Russa 1.008
DE - Germania 869
SE - Svezia 633
CA - Canada 519
IE - Irlanda 478
FR - Francia 398
BD - Bangladesh 350
GB - Regno Unito 342
IN - India 319
KR - Corea 217
AT - Austria 168
FI - Finlandia 165
ID - Indonesia 162
NL - Olanda 160
AR - Argentina 136
UA - Ucraina 134
MX - Messico 114
TR - Turchia 114
IQ - Iraq 109
ES - Italia 105
ZA - Sudafrica 95
JP - Giappone 86
PL - Polonia 86
PK - Pakistan 82
CH - Svizzera 74
DK - Danimarca 73
PH - Filippine 64
EC - Ecuador 60
VE - Venezuela 55
SA - Arabia Saudita 50
CO - Colombia 47
AU - Australia 38
UZ - Uzbekistan 37
LT - Lituania 33
BE - Belgio 32
TN - Tunisia 32
CL - Cile 31
MA - Marocco 29
PY - Paraguay 27
AE - Emirati Arabi Uniti 23
CR - Costa Rica 23
EG - Egitto 23
GR - Grecia 23
JO - Giordania 23
MY - Malesia 22
PE - Perù 22
UY - Uruguay 21
ET - Etiopia 19
PT - Portogallo 19
DZ - Algeria 16
KE - Kenya 15
NP - Nepal 15
AZ - Azerbaigian 13
KZ - Kazakistan 13
TW - Taiwan 12
AL - Albania 11
IL - Israele 11
LB - Libano 11
OM - Oman 11
BY - Bielorussia 10
CZ - Repubblica Ceca 10
DO - Repubblica Dominicana 10
JM - Giamaica 10
RS - Serbia 10
TH - Thailandia 10
IR - Iran 9
SC - Seychelles 9
RO - Romania 8
AO - Angola 7
BO - Bolivia 7
LV - Lettonia 7
PA - Panama 7
SI - Slovenia 7
SY - Repubblica araba siriana 7
HU - Ungheria 6
KG - Kirghizistan 6
PS - Palestinian Territory 6
SN - Senegal 6
BG - Bulgaria 5
MN - Mongolia 5
NG - Nigeria 5
NO - Norvegia 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
HN - Honduras 4
LY - Libia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
GA - Gabon 3
GE - Georgia 3
HR - Croazia 3
MD - Moldavia 3
MU - Mauritius 3
Totale 33.954
Città #
Singapore 2.288
Ann Arbor 1.479
Ashburn 1.451
San Jose 1.376
Hong Kong 1.192
Milan 770
Ho Chi Minh City 649
Hanoi 537
Frankfurt am Main 531
Dallas 504
Los Angeles 481
Dublin 460
New York 433
Hefei 418
Fairfield 387
Santa Clara 355
Chandler 346
Toronto 339
Wilmington 291
Beijing 267
Chicago 246
Houston 240
Woodbridge 219
The Dalles 203
Seoul 191
Seattle 174
Buffalo 163
Lauterbourg 144
Council Bluffs 137
Princeton 134
São Paulo 134
Dearborn 133
Boardman 122
Cambridge 115
Jakarta 109
Rome 109
Vienna 107
Shanghai 105
Moscow 97
Da Nang 91
Helsinki 88
Orem 86
Jacksonville 83
Munich 82
London 78
Montreal 78
Warsaw 72
Denver 67
Haiphong 64
Tokyo 64
Nanjing 61
Nuremberg 58
Chennai 55
Dong Ket 54
Kent 54
Altamura 52
Johannesburg 50
Lawrence 50
Atlanta 48
Guangzhou 48
Naples 45
Phoenix 45
Florence 43
Ha Long 43
Baghdad 42
Hải Dương 42
Brooklyn 40
Stockholm 39
Zurich 39
Busto Arsizio 37
Lappeenranta 37
Bologna 36
Monza 36
Poplar 36
Mexico City 34
Salt Lake City 34
Tashkent 34
Amsterdam 33
Dhaka 33
Istanbul 33
Manchester 33
Rio de Janeiro 33
Sesto San Giovanni 33
Washington 33
Thái Nguyên 32
Biên Hòa 31
Boston 30
Bắc Ninh 30
Can Tho 30
Lissone 30
New Delhi 29
Ninh Bình 29
Pune 29
Turin 29
Vũng Tàu 29
Paris 28
Quito 28
Quận Bình Thạnh 27
Turku 27
Cinisello Balsamo 26
Totale 20.176
Nome #
Destructuring glomerular diseases with structured deposits: challenges in the precision medicine era 587
The putative role of MALDI-MSI in the study of Membranous Nephropathy 429
Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics 422
The proteomic landscape of renal tumors 400
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 398
MALDI imaging in Fabry nephropathy: a multicenter study 392
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 391
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 381
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 377
MiralysTM Ambergen. Sequential MALDI-HiPLEX-IHC and untargeted protein imaging to map the tumour-immune environment: academic researcher experience 374
Sequential MALDI-HiPLEX-IHC and Untargeted Spatial Proteomics Mass Spectrometry Imaging to Detect Proteomic Alterations Associated with Tumour Infiltrating Lymphocytes 374
Kidney Involvement 373
Picture this: Mass Spectrometry Imaging to unveil the multiomic layers of the tumor immune environment 371
PD-L1 Testing and Squamous Cell Carcinoma of the Head and Neck: A Multicenter Study on the Diagnostic Reproducibility of Different Protocols 371
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 369
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 363
Proteomic profiles of thyroid tumors by Mass Spectrometry-Imaging on Tissue Microarrays 351
Feasibility of MALDI-MSI-Based Proteomics Using Bouin-Fixed Pathology Samples: Untapping the Goldmine of Nephropathology Archives 350
Proteomics for the study of new biomarkers in Fabry disease: State of the art 346
Cytopathology of Bronchoalveolar Lavages in COVID-19 Pneumonia: A Pilot Study 343
Spatial resolution of renal amyloid deposits through MALDI-MSI: a combined digital and molecular approach to monoclonal gammopathies 341
Histoproteomic characterization of localized cutaneous amyloidosis in X-linked reticulate pigmentary disorder 335
"Pathologists in Venice - Real World Cases for an Immersive Training Experience": Education, Gaming, and Show 328
Digital counting of tissue cells for molecular analysis: the QuANTUM pipeline 322
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 318
Proteome analysis in thyroid pathology 317
Granulomatosis with polyangiitis presenting with diffuse alveolar hemorrhage requiring extracorporeal membrane oxygenation with rapid multiorgan relapse: A case report 312
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 311
Diagnostic performances of the acr-tirads system in thyroid nodules triage: A prospective single center study 310
Benchmarking digital displays (monitors) for histological diagnoses: the nephropathology use case 301
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 301
Pediatric immune myelofibrosis (PedIMF) as a novel and distinct clinical pathological entity 300
Use of diagnostic criteria from acr and eu-tirads systems to improve the performance of cytology in thyroid nodule triage 299
Machine learning streamlines the morphometric characterization and multi-class segmentation of nuclei in different follicular thyroid lesions: everything in a NUTSHELL 295
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 282
Debating the pros and cons of computational pathology at the European Congress of Pathology (ECP) 2024 280
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 273
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 272
Nodal monoclonal CD5-positive B-lymphocytosis and toxoplasma lymphadenitis: Another variant in the spectrum of infectious lymphadenitis in patients with chronic leukemia/small lymphocytic lymphoma 271
Dissecting the histological features of lupus nephritis highlights new common patterns of injury in class III/IV 260
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 260
Improvements in digital pathology equipment for renal biopsies: updating the standard model 257
Immunosuppression in idiopathic membranous nephropathy: A double-edge sword 256
Lipids, proteins, cells: advanced spatial multiomics to delve deeper into the complex molecular and cellular landscape of the tumour microenvironment 250
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 249
The therapeutic potential of an allosteric non-competitive CXCR1/2 antagonist for diabetic nephropathy 246
More than an ‘atypical’ phenotype: dual molecular diagnosis of autoimmune lymphoproliferative syndrome and Becker muscular dystrophy 243
MALDI-MS imaging in the study of glomerulonephritis 242
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 239
The Complex Cyto-Molecular Landscape of Thyroid Nodules in Pediatrics 234
Digital transition in pathology lab: a survey from the Lombardy region 233
Displaced Cartilage Within Lymph Node Parenchyma Is a Novel Biopsy Site Change in Resected Mediastinal Lymph Nodes Following EBUS-TBNA 231
Enhancing proteomics characterization of thyroid nodules: a pixel-classifier for mass spectrometry imaging analyses 230
Deep learning helps discriminate between autoimmune hepatitis and primary biliary cholangitis 227
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 226
Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis 226
The value of the current histological scores and classifications of ANCA glomerulonephritis in predicting long-term outcome 225
An Indeterminate for Malignancy FNA Report Does Not Increase the Surgical Risk of Incidental Thyroid Carcinoma 224
6-Aza-2-Thiothymine as an Alternative Matrix for Spatial Proteomics with MALDI-MSI 222
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 222
Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms with Papillary-like Nuclear Features (NIFTPs) Identifies a Distinct Proteomic Signature Associated with RAS-Mutant Lesions 221
A Mass Spectrometry Imaging-based multiomics approach to map the tumour-immune landscape of clear cell Renal Cell Carcinoma and gain insights into resistance to immunotherapy 221
Tumour incidence in Fabry disease: A cross-sectional study 220
Goodpasture syndrome and anti-glomerular basement membrane disease 219
Anticoagulant-related nephropathy: a pathological note 217
The role of digital and integrative pathology for the detection of translocations: a narrative review 216
Digital twin manifesto for the pathology laboratory 215
The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUM 214
Different clusters in patients with lupus podocytopathy identified by clinical-pathological characteristics 214
Congo Red Staining in Digital Pathology: The Streamlined Pipeline for Amyloid Detection Through Congo Red Fluorescence Digital Analysis 211
Economic assessment of NGS testing workflow for NSCLC in a healthcare setting 210
Monoclonal Gammopathy of Renal Significance: A Molecular Middle Earth between Oncology, Nephrology, and Pathology 206
Kidney Function, CKD Causes, and Histological Classification 206
Effect of Sustained Clinical Remission on the Risk of Lupus Flares and Impaired Kidney Function in Patients With Lupus Nephritis 204
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 203
Un nuovo approccio basato sull’Imaging con Spettrometria di Massa per la sottotipizzazione dell’amiloidosi renale [A novel mass spectrometry imaging based approach for the subtyping of renal amyloidosisn] 202
Automate the process of formalin-fixed paraffin-embedded blocks storage in the pathology laboratory: A proof of concept study 202
Digital Pathology Applications for PD-L1 Scoring in Head and Neck Squamous Cell Carcinoma: A Challenging Series 201
The putative role of MALDI-MSI in the study of Membranous Nephropathy 201
Digital pathology for the routine diagnosis of renal diseases: a standard model 198
Proteomics and glomerulonephritis: A complementary approach in renal pathology for the identification of chronic kidney disease related markers 198
The putative role of MALDI-MSI in the study of Membranous Nephropathy 194
Pathologist Validation of a Machine Learning-Derived Feature for Colon Cancer Risk Stratification 193
JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib 193
Artificial intelligence–based algorithms for the diagnosis of prostate cancer: A systematic review 192
Renal involvement in eosinophilic granulomatosis with polyangiitis 192
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 192
#EBUSTwitter: Novel use of social media for conception, coordination, and completion of an international, multicenter pathology study 192
Bone Marrow CD8 + Abundance Inversely Correlates with Progressive Marrow Fibrosis and Myelodysplastic Evolution in GATA2 Deficiency: Case Report 190
Systemic vasculitis involving the kidney: the nephropathologist's point of view 188
Autopsia di Innocenzo XII. Un’attestazione dell’utilizzo del microscopio in ambito necroscopico nel XVII secolo 188
MALDI-MS Imaging of glomerular diseases: A possible diagnostic role? 186
Liquid-based shaking of core needle biopsy samples for the molecular characterization of tumors: A fallback in cytopathology 186
The Puzzle of Preimplantation Kidney Biopsy Decision-Making Process: The Pathologist Perspective 185
Changing Phenotypes and Clinical Outcomes Over Time in Microscopic Polyangiitis 184
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 183
Galileo—an Artificial Intelligence tool for evaluating pre-implantation kidney biopsies 183
MALDI-MS Imaging in Membranous Nephropathy: from the research to the clinical laboratory? 181
Delving deeper into the Tumour Microenvironment: a MS-driven spatial multiomics approach to provide new molecular insights into immune-tumour cell communication 180
Imaging molecolare a livello cellulare: possiamo predire la risposta alla terapia nella Nefropatia Membranosa? 179
Totale 26.492
Categoria #
all - tutte 104.103
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.103


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021167 0 0 0 0 0 0 0 0 0 0 0 167
2021/20221.189 145 131 127 68 68 101 26 79 33 83 123 205
2022/20231.928 185 503 193 146 106 275 53 144 164 41 81 37
2023/20241.950 67 85 86 121 190 442 351 70 175 40 87 236
2024/20256.832 234 517 624 277 469 287 329 219 645 1.000 884 1.347
2025/202618.814 2.259 1.479 1.468 2.059 1.886 853 2.698 820 1.318 1.806 1.584 584
Totale 34.753